ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
N-Zyme Biomedical raised US$4.6 million in Series A financing. The round supports development of the company's enzyme-based diagnostic platform. The funding will advance clinical trials and expand the team.
Tap to vote and see what everyone thinks.
Summary by ByteBrief